BIOCARDIA INC

Biocardia’s shares fell 5.8% as CEO Peter Altman bought 500 more shares—yet the stock’s low liquidity, weak pipeline and lack of earnings keep investors skeptical.

Biocardia’s stock jumps 15.6% as CEO Peter Altman buys shares at a discount, sparking optimism despite the company’s speculative outlook.

Biocardia (BCDA) shares fell 2.17% to $1.05, trading at a $13.9M cap with 15.1M shares outstanding—key stats, recent trends, and a quick market snapshot.